子宫镜检查手术市场按类型、设备类型、技术、最终用户、应用、手术环境和组件划分 - 全球预测 2025-2032

预计到 2032 年，子宫镜检查手术市场规模将达到 87.8 亿美元，复合年增长率为 8.06%。

关键市场统计数据
基准年 2024	47.2亿美元
预计年份：2025年	51.1亿美元
预测年份 2032	87.8亿美元
复合年增长率 (%)	8.06%

本书精闢地介绍了临床、技术和医疗服务提供者等方面的变化如何再形成子宫镜检查诊疗模式和器械选择重点。

随着光学、仪器和临床通讯协定的不断改进，子宫镜检查已从专门的诊断工具发展成为微创妇科诊疗的核心组成部分。近年来，临床医生已将子宫腔镜的适应症从单纯的检查扩展到息肉和肌瘤的切除（包括硬式和软式两种技术），以及粘连松解术和子宫内膜消融术等治疗性介入。这种发展迫使医疗系统和门诊服务提供者重新评估其工作流程、资金分配和培训需求，以支持日益增长的门诊手术量。

同时，医疗器材製造商正努力应对临床医生对一次性器材的偏好、成本控制压力以及与可重复使用系统相关的永续性问题等复杂挑战。配备视讯影像功能的软式子宫腔镜因其提升患者舒适度和手术效率而日益普及，而硬式宫腔镜对于某些外科手术仍然必不可少。临床疗效、器械人体工学以及单次手术成本之间的相互作用，共同影响采购决策和市场定位。

本导言透过重点阐述影响子宫镜检查服务提供和组装的临床需求、技术差异化以及医疗服务提供者动态，为后续分析奠定了基础。对于那些致力于将产品开发、商业化和临床应用策略与患者照护和医疗服务提供相关人员效率的显着提升相结合的利害关係人而言，理解这些基本要素至关重要。

光学、一次性使用和护理过渡的整合进步如何推动子宫镜检查生态系统的策略变革

随着光学、耗材和服务提供方面的创新与更广泛的医疗保健系统趋势相融合，子宫镜检查领域正经历着变革性的转变。如今，具备视讯功能的柔性子宫镜能够提供更高解析度的影像，并与数位化手术环境实现更高效的集成，使临床医生能够更精准地进行诊断测试和治疗操作。同时，一次性使用设备以其更快的更换速度和更低的交叉感染风险，对传统的重复使用模式提出了挑战，但也引发了人们对环境影响和单次手术成本之间权衡取舍的思考。

同时，医疗保健向门诊手术中心和门诊病人模式的转变正在加速手术流程，迫使供应商提供占地面积小、安装简单且具有互通性的紧凑型系统。不断变化的法规和对感染​​预防日益严格的审查进一步推动了一次性配件和简化再处理流程的应用。这些转变，加上手术适应症的不断扩大（例如子宫肌瘤和息肉切除术的日益普及），都促使製造商拓展工作通道的兼容性，并提供功能全面的器械产品组合。

因此，製造商、医疗服务提供者和支付者必须适应市场变化，在这个市场中，临床偏好、营运效率和环境因素相互交织，共同决定着竞争的胜负。将产品差异化与清晰的经济和临床意义相结合的策略性应对措施，对于赢得医生的忠诚度和医疗机构的采购承诺至关重要。

评估2025年关税调整对子宫镜检查链和医疗服务提供者准入的营运、采购和策略影响。

2025年关税及相关贸易措施的实施将为全球子宫镜检查设备供应链带来新的复杂性，并对生产、采购和临床应用产生连锁反应。关税调整推高了部分市场进口零件和成品的相对成本，迫使製造商重新评估筹资策略和库存计画。为此，一些供应商正在寻求製造地多元化、加快近岸外包或重新谈判供应商合约以缓解利润压力。

这些商业性应对措施也影响经销商和医疗服务提供者，他们面临前置作业时间缩短和价格调整的风险。高度依赖进口一次性医疗设备的医疗机构现在不得不评估替代供应商、重新评估合约条款或增加本地库存水平，以确保医疗服务的连续性。当关税与区域报销限制相互作用时，决策者需要在有限的采购预算和先进内视镜及配件的临床效益之间权衡利弊。

除了直接的成本影响外，关税还促使企业进行更长期的策略调整，包括与区域委託製造合作以及加大对国内产能的投资。对于价值链上的相关人员，任务十分明确：将贸易政策的敏感性纳入筹资策略，保持营运灵活性，并加强供应协议，以确保在不断变化的关税环境下，关键的子宫镜检查技术能够持续供应。

全面的細項分析揭示了设备类型、技术、最终用户、应用、手术环境和组件如何决定采购和临床选择。

深入的市场细分揭示了子宫镜检查领域设备选择、临床路径和采购偏好背后的细微驱动因素。按类型划分，市场可分为诊断应用和手术应用，后者需要更完善的通道管理和仪器相容性。按设备类型划分，可重复使用系统和一次性系统之间的选择反映了资本投资、週转时间和感染控制优先顺序之间的权衡。从技术角度来看，刚性平台和柔性平台并存，柔性系统又分为光纤和视讯格式，每种格式都有不同的成像特性和整合需求。

终端使用者细分突显了门诊手术中心、诊所和医院在营运和采购行为上的差异。门诊患者倾向于精简的工作流程和快速的周转，诊所强调诊断效率，而医院则需要在复杂的手术能力和广泛的服务范围之间取得平衡。基于应用的差异——例如粘连松解术、诊断性检查、子宫内膜切除术、子宫肌瘤切除术和息肉切除术——决定了设备的功能需求，例如工作通道尺寸、电外科相容性和内视镜弯曲度。手术设置细分区分了住院和门诊病人服务模式，从而影响了报销考量和资本配置模式。

组件细分揭示了一个由附件、充气介质和内视镜本身组成的生态系统，附件可进一步细分为器械和歧管，这些设备和歧管决定了操作能力以及诊断和手术用途之间的转换。整合这些细分层级，可以深入了解产品创新、定价模式和临床培训将在哪些方面产生最大影响。

美洲、欧洲、中东和非洲以及亚太地区的招募细微差别和供应链差异。

区域洞察揭示了主要区域在产品应用模式、报销机制和供应链结构方面的差异。在美洲，一次性医疗器材和具备视讯功能的软式子子宫镜的应用正在加速成长，同时门诊手术中心也蓬勃发展，感染防治工作日益受到重视。该地区的采购往往受到私人支付方趋势和医疗系统整合的影响，进而影响产品规格和采购週期。

欧洲、中东和非洲各地的法律规范和医疗基础设施各不相同，导致可重复使用医疗器材的普及速度存在差异。一些市场正在迅速提升手术能力并投资建造门诊手术中心，而另一些市场则面临预算限制，更倾向于采用可重复使用系统。当地的生产製造和进口法规也对供应策略和定价有关键影响。

亚太地区的情况十分复杂，手术量快速增长，公私合作计画不断推进以扩大医疗服务覆盖范围，同时，微创妇科领域也获得了重点投资。大都会圈的高手术量中心已率先采用视讯辅助的灵活技术，但该技术在该地区更广泛的普及将取决于可扩展的培训项目以及与国家采购流程的契合度。认识到这些区域差异将有助于相关人员调整其市场准入策略、销售合作关係和临床教育项目，从而最大限度地发挥其影响力。

现有产品组合、颠覆性的一次性产品参与企业以及策略伙伴关係关係如何重新定义子宫镜检查设备市场的竞争优势

子宫镜检查领域的竞争格局正受到以下因素的影响：现有製造商不断拓展其器械产品线；新兴参与企业专注于一次性系统；以及利基创新者进一步整合影像处理和配件。现有製造商继续利用其品牌知名度、服务网络以及包含内视镜、可重复使用器械和扩张解决方案的捆绑式产品。另一方面，灵活的挑战者则透过价格策略来吸引那些寻求一次性创新、简化抛弃式和可预测的单次手术成本的门诊医疗机构，从而实现差异化竞争。

医疗器材製造商与临床中心之间的伙伴关係正变得日益策略化，双方能够共同开发优化工作流程的系统和实证实践倡议，从而展现临床和营运效益。投资于能够促进培训、远端指导和影像共用的数位化工具，是影响临床医生偏好的关键差异化因素。此外，能够提供包括器械、歧管和相容充气介质在内的完整配件生态系统的製造商，可以透过减少采购流程和支援复杂的手术适应症而获得竞争优势。

智慧财产权，包括成像平台、人体工学和一次性使用製造工艺，仍然是企业竞争地位的核心。那些将产品创新与明确的临床结果、营运效率和永续的供应链策略相结合的公司，最有可能获得机构的认可和临床医生的长期支持。

为製造商和医疗保健提供者制定可操作的策略重点，以协调产品、采购、临床证据和商业化，从而实现持续推广和成长。

为了掌握子宫镜检查领域的新兴机会，产业领导者应采取整合策略，平衡临床疗效、营运效率和供应链韧性。首先，产品开发应与诊断和手术流程的独特需求相契合，优先考虑高解析度视讯成像、多功能工作通道以及可互通的数位系统等功能，从而简化文件记录和指导流程。其次，采用灵活的生产和采购方式，可降低关税波动带来的风险，并支持可重复使用和一次性产品线的快速扩张。

第三，我们将投资于真实世界证据和有针对性的临床合作，以检验手术在粘连松解术、子宫肌瘤和息肉切除术以及子宫内膜消融术等应用中的益处。第四，我们将设计能够反映不同终端使用者差异的商业化模式，为门诊手术中心、诊所和医院提供相应的服务、培训和定价。第五，我们将把环境和生命週期因素纳入产品设计和上市后计划，以解决医疗服务提供者和支付永续性的担忧。

最后，应优先考虑临床医生教育数位化（远端指导、模拟、整合影像平台），以加速技术应用并减少操作差异。透过落实这些优先事项，领导者可以将技术差异化转化为持续的临床应用和可衡量的营运成果。

严谨的二级调查方法见解，结合了主要相关人员访谈、二级临床和监管证据以及供应链三角验证。

本分析采用结构化的调查方法，整合了第一手资料、二手文献和三角验证的定性证据，以确保得出平衡且切实可行的结论。第一手资料包括对临床医生、采购负责人和医疗器材主管的访谈，以了解他们对技术偏好、流程和采购驱动因素的现场观点。二手资料涵盖了同行评审的临床文献、监管指南和行业出版物，以揭示临床疗效、安全性考虑和产品核可背景。

资料整合着重于跨区域和跨终端使用者类型的主题交叉检验，以避免过度依赖任何单一资料来源。在适用情况下，对设备功能（包括显像模式、一次性使用和配件生态系统）进行了比较评估，以评估相对差异，但并未确定市场规模。调查方法还考虑了供应链变量，包括製造地、关税风险和分销模式，以评估营运风险和韧性。

透过反覆的同侪评审，我们保持了分析的严谨性，确保结论反映当前的临床实践和合理的商业性发展轨迹。考虑到监管政策的不断变化以及2024年后的发展趋势，我们鼓励相关人员在做出时效性决策时，持续监测相关政策和临床试验结果，以补充本报告。

策略结论强调，需要将临床差异化、营运叙事和供应链弹性结合，以确保长期应用。

临床创新、营运优化和采购动态的变化凸显了子宫镜相关人员所处的这一关键时刻。临床医生受益于更清晰的视野和更佳的器械相容性，从而拓展了子宫镜检查的治疗范围；而医疗机构和製造商则必须权衡可重复使用与一次性使用模式、环境因素以及不断变化的手术环境等问题。在这些方面，策略上的清晰性将决定哪些机构能够将创新转化为持续的临床应用和组织采购。

未来的成功取决于能否展现出显着的临床优势，能否清楚阐述营运和经济效益，以及能否维持灵活的供应和生产策略以应对政策衝击。那些投资于针对性临床证据、无缝数位整合以及面向门诊、诊所和医院等不同环境的商业化的企业，将更有利于赢得临床医生的信任和长期合约。

最终，子宫镜检查领域将奖励那些将技术差异化与务实的培训、永续性和供应链弹性方法相结合的公司。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 一次性子子宫镜的广泛使用导致了门诊护理中子宫腔镜使用率的提高。
• 3D影像技术的整合提高了复杂子宫疾病的诊断准确性。
• 远端医疗的普及使得术前评估成为可能，并改善了患者获得子宫镜检查服务的机会。
• 市场对能够缩短手术时间和患者恢復时间的整合式电外科器械的需求日益增长。
• 人工智慧驱动的影像分析技术发展迅速，可用于支援子宫镜检查过程中子宫内膜病变的自动检测。
• 重视微创门诊中心正在改变子宫镜检查手术的经济模式
• 一次性液体管理系统的出现，优化了子宫扩张并减少了併发症。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章子宫镜检查手术市场（按类型划分）

• 诊断
• 外科手术

第九章 依设备类型分類的子子宫镜检查手术市场

• 可重复使用的
• 一次性的

第十章 依技术分類的子子宫镜检查手术市场

• 灵活的
  • 光纤
  • 影片
• 死板的

第十一章 以最终用户分類的子宫镜检查手术市场

• 门诊手术中心
• 诊所
• 医院

第十二章 按应用分類的子子宫镜检查手术市场

• 黏附溶解
• 诊断测试
• 子宫内膜消融术
• 子宫肌瘤切除术
• 息肉切除术

第十三章 依手术场所分類的子宫镜检查手术市场

• 住院病人
• 门诊

第十四章子宫镜检查手术市场（按组件划分）

• 配件
  • 装置
  • 歧管
• 远端媒体
• 范围

第十五章 各地区子宫镜检查手术市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章子宫镜检查手术市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十七章 各国子子宫镜检查手术市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Richard Wolf GmbH
  • Stryker Corporation
  • Smith & Nephew plc
  • CONMED Corporation
  • CooperSurgical, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Ambu A/S

The Hysteroscopy Procedures Market is projected to grow by USD 8.78 billion at a CAGR of 8.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.72 billion
Estimated Year [2025]	USD 5.11 billion
Forecast Year [2032]	USD 8.78 billion
CAGR (%)	8.06%

An incisive introduction to how clinical, technological, and provider dynamics are reshaping hysteroscopy care delivery and device priorities

Hysteroscopy has evolved from a specialized diagnostic tool into a central component of minimally invasive gynecologic care, driven by continuous refinements in optics, instrumentation, and clinical protocols. Recent years have seen clinicians expand indications beyond inspection to therapeutic interventions such as polyp and fibroid removal, adhesiolysis, and endometrial ablation using both rigid and flexible technologies. This progression has prompted health systems and ambulatory providers to reassess workflows, capital allocation, and training needs to support higher procedure volumes in outpatient settings.

Concurrently, device manufacturers are navigating a complex intersection of clinician preference for single-use disposables, cost-containment pressures, and sustainability concerns tied to reusable systems. Flexible scopes with video imaging are gaining traction for patient comfort and procedural efficiency, while rigid hysteroscopes remain indispensable for certain operative interventions. The interplay of clinical outcomes, device ergonomics, and per-procedure economics shapes purchasing decisions and competitive positioning.

This introduction frames the rest of the analysis by highlighting the clinical imperatives, technological differentiation, and provider dynamics that influence how hysteroscopy services are delivered and supported. Understanding these fundamentals is essential for stakeholders seeking to align product development, commercialization, and clinical adoption strategies with meaningful improvements in patient care and provider throughput.

How converging advances in optics, disposability, and care migration are driving strategic disruption across the hysteroscopy ecosystem

The landscape for hysteroscopy is experiencing transformative shifts as innovations in optics, disposability, and service delivery intersect with broader healthcare system trends. Video-capable flexible hysteroscopes now offer higher-resolution imaging and streamlined integration with digital operating environments, enabling clinicians to perform diagnostic inspection and therapeutic procedures with greater precision. Meanwhile, single-use devices are challenging legacy reusable models by promising shorter turnover times and reduced cross-contamination risk, while raising questions about environmental impact and per-procedure cost trade-offs.

Simultaneously, care migration toward ambulatory surgery centers and outpatient settings is accelerating procedural throughput and compelling vendors to provide compact, interoperable systems that minimize footprint and setup complexity. Regulatory evolution and heightened scrutiny on infection prevention have further incentivized adoption of disposable accessories and simplified reprocessing pathways. These shifts are compounded by expanding procedural indications-such as increasingly common utilization for fibroid and polyp removal-requiring manufacturers to broaden working-channel compatibility and deliver versatile instrument portfolios.

As a result, manufacturers, providers, and payers must adapt to a marketplace where clinical preferences, operational efficiency, and environmental considerations converge to determine the competitive winners. Strategic responses that align product differentiation with clear economic and clinical narratives will be decisive in capturing physician loyalty and institutional procurement commitments.

Assessing the operational, sourcing, and strategic consequences of 2025 tariff changes on the hysteroscopy device supply chain and provider access

The implementation of tariffs and related trade measures in 2025 is imposing new layers of complexity on the global supply chain for hysteroscopy devices, with implications that cascade through manufacturing, procurement, and clinical access. Tariff adjustments have increased the relative cost of imported components and finished devices in some markets, prompting manufacturers to reassess sourcing strategies and inventory planning. In response, several suppliers have moved to diversify their manufacturing footprint, accelerate nearshoring initiatives, or renegotiate supplier contracts to mitigate margin pressure.

These commercial responses have also affected distributors and healthcare providers who face tighter lead times and potential price adjustments. Facilities with high reliance on imported single-use devices have had to evaluate alternative suppliers, revisit contract terms, or increase local stocking levels to ensure continuity of care. Where tariffs interact with regional reimbursement constraints, decision-makers are balancing the clinical benefits of advanced scopes and accessories against constrained procurement budgets.

Beyond immediate cost impacts, tariffs are stimulating longer-term strategic shifts such as partnerships with regional contract manufacturers and incremental investments in domestic production capabilities. For stakeholders across the value chain, the mandate is clear: incorporate trade-policy sensitivity into sourcing strategies, maintain operational flexibility, and fortify supply agreements to preserve access to critical hysteroscopy technologies amid evolving tariff environments.

Comprehensive segmentation analysis to reveal how device type, technology, end user, applications, procedure setting, and components determine procurement and clinical choices

In-depth segmentation reveals the nuanced drivers behind device selection, clinical pathways, and procurement preferences across the hysteroscopy domain. Based on type, the market differentiates diagnostic uses from operative procedures, with the latter demanding enhanced channel management and instrument compatibility. Based on device type, choices between reusable systems and single-use devices reflect trade-offs among capital investment, turnaround time, and infection-control priorities. Based on technology, rigid and flexible platforms coexist, while flexible systems themselves split between fiberoptic and video modalities, each offering distinct imaging characteristics and integration requirements.

End-user segmentation highlights the distinct operational and procurement behaviors among ambulatory surgery centers, clinics, and hospitals, with ambulatory settings favoring compact workflows and rapid turnover, clinics focusing on diagnostic throughput, and hospitals balancing complex operative capacity with broader service lines. Application-based distinctions-adhesiolysis, diagnostic inspection, endometrial ablation, fibroid removal, and polyp removal-drive device feature requirements, such as working channel size, electrosurgical compatibility, and scope deflection. Procedure setting segmentation separates inpatient from outpatient delivery models, shaping reimbursement considerations and capital allocation patterns.

Component segmentation clarifies the ecosystem of accessories, distension media, and the scope itself, with accessories further disaggregated into instruments and manifolds that determine procedural capability and conversion potential between diagnostic and operative use. Synthesizing these segmentation layers enables a granular understanding of where product innovation, pricing models, and clinical training will have the greatest impact.

Regional adoption nuances and supply-chain distinctions across the Americas, Europe, Middle East & Africa, and Asia-Pacific that inform targeted commercial and clinical strategies

Regional insights illuminate diverse adoption patterns, reimbursement contexts, and supply-chain configurations across major geographies. In the Americas, adoption of single-use devices and video-capable flexible hysteroscopes has accelerated alongside robust ambulatory surgery center expansion and heightened emphasis on infection prevention. Procurement in this region is often shaped by private payer dynamics and health-system consolidation, which together influence product specification and purchasing cycles.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and variable healthcare infrastructure creates mixed adoption speeds. Some markets are rapidly updating procedural capabilities and investing in outpatient surgical capacity, while others face budgetary constraints that favor reusable systems. Local manufacturing and import regulations in this region also play a key role in shaping supply strategies and pricing dynamics.

Asia-Pacific presents a complex blend of fast-growing surgical volumes, public and private sector initiatives to expand access, and targeted investments in minimally invasive gynecology. High-volume centers in major metropolitan areas are early adopters of video-capable flexible technologies, yet broader regional adoption depends on scalable training programs and alignment with national procurement processes. Recognizing these regional distinctions enables stakeholders to tailor market entry, distribution partnerships, and clinical education programs for maximum impact.

How incumbent portfolios, disruptive single-use entrants, and strategic partnerships are redefining competitive advantage in hysteroscopy device markets

Competitive dynamics in hysteroscopy are shaped by incumbent manufacturers expanding device portfolios, new entrants focused on single-use systems, and niche innovators advancing imaging and accessory integration. Established firms continue to leverage brand recognition, service networks, and bundled offerings that include scopes, reusable instruments, and distension solutions. Conversely, agile challengers are differentiating through single-use innovations, simplified disposables, and pricing strategies that appeal to ambulatory and outpatient providers seeking predictable per-procedure costs.

Partnerships between device makers and clinical centers are becoming more strategic, enabling co-development of workflow-optimized systems and evidence-generation initiatives that demonstrate clinical and operational benefits. Investment in training, remote proctoring, and digital tools to facilitate image sharing are further differentiators that influence clinician preference. In addition, manufacturers that provide comprehensive accessory ecosystems-covering instruments, manifolds, and compatible distension media-gain an advantage by reducing friction in procurement and supporting complex operative indications.

Intellectual property including imaging platforms, ergonomics, and single-use manufacturing processes remains central to competitive positioning. Companies that align product innovation with clear clinical outcomes, operational efficiencies, and sustainable supply strategies will be best positioned to win institutional commitments and long-term clinician endorsement.

Actionable strategic priorities for manufacturers and providers to align product, sourcing, clinical evidence, and commercialization for durable adoption and growth

Industry leaders should pursue an integrated strategy that balances clinical efficacy, operational efficiency, and supply resilience to capture emerging opportunities in hysteroscopy. First, align product development with the distinct needs of diagnostic and operative workflows by prioritizing features such as high-resolution video imaging, versatile working channels, and interoperable digital systems that streamline documentation and teaching. Second, adopt a flexible manufacturing and sourcing approach that reduces exposure to tariff volatility and supports rapid scaling of both reusable and single-use product lines.

Third, invest in real-world evidence and targeted clinical partnerships to validate procedural benefits across applications including adhesiolysis, fibroid and polyp removal, and endometrial ablation; these data support reimbursement discussions and strengthen procurement value propositions. Fourth, design commercialization models that reflect end-user differences-tailoring offerings for ambulatory surgery centers, clinics, and hospitals with appropriate service, training, and pricing structures. Fifth, incorporate environmental and lifecycle considerations into product design and post-market programs to address provider and payer concerns about sustainability.

Finally, prioritize clinician education and digital enablement-remote proctoring, simulation, and integrated imaging platforms-to accelerate adoption and reduce procedural variation. Executing on these priorities will enable leaders to translate technical differentiation into durable clinical adoption and measurable operational outcomes.

Robust mixed-methods research methodology combining primary stakeholder interviews, secondary clinical and regulatory evidence, and supply-chain triangulation for rigorous insights

This analysis is informed by a structured research methodology that synthesizes primary insights, secondary literature, and triangulated qualitative evidence to ensure balanced, actionable conclusions. Primary inputs included interviews with clinicians, procurement leaders, and device executives to capture frontline perspectives on technology preferences, procedural workflows, and purchasing drivers. Secondary inputs encompassed peer-reviewed clinical literature, regulatory guidance, and industry announcements to contextualize clinical efficacy, safety considerations, and product approvals.

Data synthesis emphasized cross-validation of themes across geographies and end-user types to avoid overreliance on any single data source. Where applicable, comparative assessment of device capabilities-such as imaging modality, disposability, and accessory ecosystems-was conducted to evaluate relative differentiation without assigning market sizing. The methodology also accounted for supply-chain variables including manufacturing locations, tariff exposures, and distribution models to assess operational risk and resilience.

Analytical rigor was maintained through iterative review cycles with subject-matter experts, ensuring that conclusions reflect contemporary clinical practice and plausible commercial trajectories. Limitations related to evolving regulatory changes and post-2024 developments were acknowledged, and stakeholders are advised to supplement this report with ongoing surveillance of policy and clinical trial outcomes for time-sensitive decisions.

Strategic conclusion emphasizing the necessity to combine clinical differentiation, operational narratives, and supply resilience to secure long-term adoption

The convergence of clinical innovation, operational optimization, and shifting procurement dynamics underscores a pivotal moment for hysteroscopy stakeholders. Clinicians are benefiting from improved visualization and instrument compatibility that expand the therapeutic scope of hysteroscopy, while providers and manufacturers must navigate decisions around reusable versus single-use paradigms, environmental considerations, and evolving procedural settings. Strategic clarity on these dimensions will determine which organizations convert innovation into sustained clinical adoption and institutional procurement.

Moving forward, success will hinge on the capacity to demonstrate meaningful clinical advantages, articulate clear operational and economic narratives, and maintain flexible supply and manufacturing strategies that absorb policy-induced shocks. Companies that invest in targeted clinical evidence, seamless digital integration, and tailored commercialization for ambulatory, clinic, and hospital settings will be better positioned to capture clinician loyalty and long-term contracts.

Ultimately, the hysteroscopy landscape rewards those who marry technical differentiation with pragmatic approaches to training, sustainability, and supply resilience, thereby enabling improved patient outcomes while meeting the operational realities of modern healthcare delivery.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Expansion of disposable hysteroscopes driving adoption in outpatient settings
• 5.2. Integration of 3D imaging technology enhancing diagnostic accuracy in complex uterine cases
• 5.3. Surge in telemedicine enabled preoperative assessments improving patient access to hysteroscopy services
• 5.4. Rising demand for integrated electrosurgical instruments reducing procedure time and patient recovery period
• 5.5. Growth of AI driven image analysis supporting automated detection of endometrial pathologies during hysteroscopy
• 5.6. Increased focus on minimally invasive outpatient centers transforming economic models for hysteroscopy procedures
• 5.7. Emergence of single use fluid management systems optimizing uterine distension and reducing complications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hysteroscopy Procedures Market, by Type

• 8.1. Diagnostic
• 8.2. Operative

9. Hysteroscopy Procedures Market, by Device Type

• 9.1. Reusable
• 9.2. Single Use

10. Hysteroscopy Procedures Market, by Technology

• 10.1. Flexible
  • 10.1.1. Fiberoptic
  • 10.1.2. Video
• 10.2. Rigid

11. Hysteroscopy Procedures Market, by End User

• 11.1. Ambulatory Surgery Centers
• 11.2. Clinics
• 11.3. Hospitals

12. Hysteroscopy Procedures Market, by Application

• 12.1. Adhesiolysis
• 12.2. Diagnostic Inspection
• 12.3. Endometrial Ablation
• 12.4. Fibroid Removal
• 12.5. Polyp Removal

13. Hysteroscopy Procedures Market, by Procedure Setting

• 13.1. Inpatient
• 13.2. Outpatient

14. Hysteroscopy Procedures Market, by Component

• 14.1. Accessories
  • 14.1.1. Instruments
  • 14.1.2. Manifolds
• 14.2. Distension Media
• 14.3. Scope

15. Hysteroscopy Procedures Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Hysteroscopy Procedures Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Hysteroscopy Procedures Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Olympus Corporation
  • 18.3.2. KARL STORZ SE & Co. KG
  • 18.3.3. Richard Wolf GmbH
  • 18.3.4. Stryker Corporation
  • 18.3.5. Smith & Nephew plc
  • 18.3.6. CONMED Corporation
  • 18.3.7. CooperSurgical, Inc.
  • 18.3.8. Boston Scientific Corporation
  • 18.3.9. Johnson & Johnson
  • 18.3.10. Ambu A/S

LIST OF FIGURES

• FIGURE 1. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. HYSTEROSCOPY PROCEDURES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. HYSTEROSCOPY PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HYSTEROSCOPY PROCEDURES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OPERATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBEROPTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY VIDEO, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY RIGID, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ADHESIOLYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DIAGNOSTIC INSPECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ENDOMETRIAL ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FIBROID REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY POLYP REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY MANIFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DISTENSION MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 167. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 168. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 169. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 170. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 171. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 172. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 173. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 174. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 175. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 176. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 177. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 178. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 179. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 180. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 181. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 182. AMERICAS HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 186. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 187. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 188. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 189. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 190. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 191. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 192. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 193. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 196. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 197. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 198. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 199. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 200. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 201. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 202. NORTH AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 203. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 206. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 207. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 208. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 209. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 210. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 211. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 212. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 213. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 214. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 215. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 216. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 217. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 218. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 219. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 220. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 221. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 222. LATIN AMERICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 243. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 244. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 245. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 246. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 247. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 248. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 263. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 266. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 267. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 268. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 269. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 270. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 271. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 272. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 273. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 274. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 275. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 276. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 277. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 278. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 279. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 280. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 281. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 282. MIDDLE EAST HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 283. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 284. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 285. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 286. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 287. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 288. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 289. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 290. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 291. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 292. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 293. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 294. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 295. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 296. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 297. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 298. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 299. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 300. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 301. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 302. AFRICA HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 303. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 304. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 305. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 306. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 307. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 308. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 309. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 310. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 311. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
• TABLE 312. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
• TABLE 313. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 314. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 315. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 316. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 317. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2018-2024 (USD MILLION)
• TABLE 318. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY PROCEDURE SETTING, 2025-2032 (USD MILLION)
• TABLE 319. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 320. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 321. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
• TABLE 322. ASIA-PACIFIC HYSTEROSCOPY PROCEDURES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
• TABLE 323. GLOBAL HYSTEROSCOPY PROCEDURES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)

TABLE